Alessandro Candreva MD PhD

Interv. cardiologist @ University Hospital Zurich | Coordinator of the angiography AGCRC CoreLaboratory | Bio-Eng. PhD in Computational Fluid Dynamics @ PoliTo

[JACC Journals @JACCJournals]

New insights from #PROSPECTII substudy of non-culprit lesions post #cvAMI found that both physiologically sig & even non-physiologically sig lesions demonstrated a moderate-to-high presence of high-risk plaque https://t.co/N1gXGeCHu5

@GreggWStone @Kketina #JACCIMG #cvImaging

[Alessandro Candreva MD PhD @alecandreva]

@DrBIqbal @KPujdak @AGIKinterv @PCRonline @CMichaelGibson @ateap0tist @Obisht @vlad_sok "trapping ballon in GE", thanks never heard of it

[American College of Cardiology @ACCinTouch]

Top 🔟 Clinical Trials of 2024:

🔥 PREVENT
🔥 DanGer Shock
🔥 REDUCE-AMI
🔥 CLEAR SYNERGY (OASIS 9)
🔥 And more!

Read the details of the clinical trials here: https://t.co/p6WuwqvYz0

[Eric Topol @EricTopol]

New @Nature
A mechanism for why durable weight loss is so difficult: epigenetic memory of fat cells
https://t.co/bfyTkvWS1P
@vonMeyenn @laurahinte

[Ashwin Rajenesh MD @ashwinrajenesh]

"Is there a doctor on the plane?"✈️🩺
Responding to in-flight medical emergencies.
#MedTwitter

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Have we come a long way in treating acute myocardial infarction? Perusing the recommendations of the 1978 Harrison's Principles of Internal Medicine will leave you appalled! https://t.co/NH4ivEYe9j @FutureLearn

[eosto @eosto1]

Please 🙏🏻 repost @OSTOLab1 @ProfPaulEvans @PaneniLab @KralerSimon @BettinaHeideck1 @alecandreva @BarteltLab @MassiRuscica @society_eas @EAPCPresident @AboyansV @BNordestgaard @Metabolcenter

[JACC Journals @JACCJournals]

New #JACCAsia state-of-the-art comprehensive review on updated clinical data of intravascular imaging–guided #PCI and #IVUS/OCT-derived stent optimization criteria in Asia. https://t.co/cfYiMKa3wL #ACCIntl

[NEJM @NEJM]

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. https://t.co/2eaS8ceLPv

#ESCardio

[Davide Capodanno @DFCapodanno]

In MATTERHORN, among patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery with respect to a composite of death, rehospitalization for heart failure, stroke, reintervention, or implantation of an assist device in the left ventricle at 1 year. Small trial, large noninferiority margin, less events than anticipated in the sample size assumption. #ESCCongress
https://t.co/fpWUtBHavU

[Coroventis Research @coroventis]

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B.

This represent a paradigm shift in the diagnosis and treatment of these patients.

[American College of Cardiology @ACCinTouch]

Measurement & interpretation of hemodynamic data are integral aspects of treating patients w/ #HeartFailure.

Read the key points from a state-of-the-art review on practical guidance for hemodynamic assessment by RHC in the management of HF. 🔗 https://t.co/KvhsvSboCp #JACCHF

[Alkadhi @Alkadhi_rad]

Great study from @MatthEberhard @mergen_v @alecandreva @rengadr @rmanka_ and others from @RadiologieUSZ and @CardioZurich

@JACCJournals

⬇️⬇️⬇️⬇️⬇️⬇️

[CTEC - Zurich University Heart Center @CTECresearch]

Congratulations to @BarbaraStahli from the @CardioZurich and @CTECresearch on winning the Georg Friedrich Götz Prize 🏆 for outstanding internationally recognized achievement! #MULTISTARS
@Unispital_USZ @UZH_en #FrankRuschitzka @FrancescoPaneni @ErsozluSara @ODzemali @PaneniLab

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Must-read review on the epidemiology and burden of heart failure in Asia in the latest issue of JACC: Asia. Highlights:
• In Asia, comprehensive data regarding the epidemiology and burden of HF remain limited.
• This review summarizes the occurrence, causes, outcomes, and management of HF in Asia, from both the GBD data and registry studies.
• HF remains a serious public health problem in Asia with significant regional variation; thus, strengthening the prevention and standardized management of HF in Asia is urgently needed.
https://t.co/WUMxAXjBVe @JACCJournals

[Alkadhi @Alkadhi_rad]

In-vivo virtual noncalcium with #photoncounting #yesCCT

-> Improved stenosis grading on noncalcium images

Fantastic collaboration with https://t.co/miniCVpMnH

https://t.co/goCkYk4LKt

@mergen_v @MatthEberhard
@rmanka_ @alecandreva @rengadr
@CardioZurich @RadiologieUSZ

[Shruti @heyshrutimishra]

The 7 best TED Talks I've ever seen:

🔖10/10 would Bookmark:

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Why Does a Cardiologist Believe in a Therapy? The Role of Intuitiveness and Understanding the Mechanism https://t.co/IJnK9x7Snv

[EuroIntervention @EuroInterventio]

Coronary computed tomographic angiography (CCTA), often combined with FFRCT, is emerging as the primary tool for diagnosing coronary artery disease, assessing hemodynamic impact, and guiding revascularization planning. It effectively rules out atherosclerosis, monitors plaque progression, and evaluates non-obstructive ischemia. In cases of significant obstruction, CCTA aids in determining disease complexity and optimizes intervention strategies, including stent or graft placement. https://t.co/JqwuVRFcD4

[Giacomo Maria Cioffi 🇨🇭🇮🇹🇨🇦 @gmcioffi]

February 22 and 23, 2024

What is it?

It is the appointment you don’t wanna miss if you’re interested in

💪🏻 challenging CHIPs
💥 calcium modification
📸 intracoronary imaging

Come join us in Lucerne if you want

🔥 debates
🔝discussions
🆒 workshops

https://t.co/cwg4r5iO7B